Prevention of Intellectual Impairment with Neonatal Hypothyroidism Screening



Prevention of Intellectual Impairment with Neonatal Hypothyroidism Screening


Mary Perry Alexander

Takara Stanley





Background

Untreated congenital hypothyroidism (CH) is known to cause impaired intellectual development and neuropsychological problems. The advent of neonatal screening for hypothyroidism in the 1970s allowed infants with low thyroxine (T4) and elevated thyroid-stimulating hormone (TSH) to be identified and treated before any clinical evidence of hypothyroidism was apparent. This study presented the intelligence quotient (IQ) outcomes for a cohort of infants found to be hypothyroid on newborn screening at a time when newborn screening programs were in their infancy.


Objectives

To determine the impact of early thyroid hormone replacement on the intellectual development of infants identified as hypothyroid on routine newborn screening.


Methods

Retrospective, case-control study in 5 US states from 1976 to 1978.


Patients

77 infants with hypothyroidism (T4 level <6 mcg/dL and TSH concentration >40 μU/dL on 2 blood tests, or between 20 to 40 μU/dL on 3 to 4 tests) diagnosed by routine screening of over 300,000 infants, and 4 infants diagnosed clinically at birth. Control group was 18 normal siblings and 39 euthyroid infants with low T4 but normal TSH.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jun 19, 2016 | Posted by in PEDIATRICS | Comments Off on Prevention of Intellectual Impairment with Neonatal Hypothyroidism Screening

Full access? Get Clinical Tree

Get Clinical Tree app for offline access